Colovic N, Rajic Z, Sretenovic M, Stojkovic M, Colovic M
Institute of hematology , Clinical Ceneter of Serbia, Belgrade.
Acta Chir Iugosl. 2004;51(2):127-31. doi: 10.2298/aci0402127c.
In this report we focus on the importance of an accurate diagnosis of gastrointestinal complications during chemotherapy for acute myeloid leukemia. The leukemic infiltrtion of the digestive system may cause mucosal ulcers which can lead to bleeding or perforation. The immune system deficiency in this cohort of patients may result in necrotic enterocolitis (leukemic typhlitis), perianal inflammation, abscesses, and peritonitis. We describe a 37-year old male who presented in June 2004 with 2-month history of fever, weakness and sore throat, treated with antibiotic therapy. Physical examination demonstrated palor. The peripheral blood count at admittance was as follow: Hemoglobin 87 g/l, WBC 63 x 10(9)/l, and platelets 56 x 10(9)/l. The peripheral blood differential count showed: myeloblasts 4%, polymorphonuclear neutrophils (PMN) 20%, monocytes 60%, lymphocytes 16%. The diagnosis of acute myeloid leukemia (AML) was confirmed by bone marrow aspirate, which presented an almost total infiltration by monocytoid blasts, AML type M5 according to FAB classification. Immunophenotypic evaluation by flow cytometry showed that the blast cells reacted with antibodies to CD33, CD13, CD14, CD64, CD15, cytogenetics showed normal karyotype. Induction treatment consisting of cytarabine 2 x 200 mg intravenously in push on days 1-8, vepeside 200 mg i.v. on days 1-5, adriblastine 90 mgon days 1,3 and 5. On day 15 of chemotherapy the patient got fever 38.5 degrees C, abdominal pain and diarrhea (10 stools daily). Broad-spectrum antibiotic therapy with ceftriaxone and amikacin was promptly instituted but condition worsened, abdominal pain extended to all abdomen while the fever and diarrhea persisted. Ultrasonography on day 18 documented bowel wall thickness of colic tract, part of duodenum and jejunum. Owing to suspicion of neutropenic enterocolitis, antibiotic therapy intensified with teicoplanin, fluconazole, metronidazole and pipril. Patient was neutropenic and thrombocytopenic, although daily platelet transfusion from a single donor were given. We started with granulocyte colony stimulating factor (G-CSF) 5 g/kg, which was adiminstered for 7 days. After 7 days neutrophil value reached 1 x 10(9)/l, but fever persisted, abdominal distension and diarrhea progressively improved. The fever peristed and central venous catheter was removed on day 30. After removal of the catheter the patient was getting better: the fever disappeared. The blood count showed Hb 91 g/l, WBC 3,4 x 10(9)/l, platelet 114 x 10(9)/l and normal leukocyte differential count. We emphesize the importance of collaboration between the hematologist and the surgeon in monitoring gastrointestinal complications during and after chemotherapy for acute leukemias and value of abdominal ultrasonography evaluation.
在本报告中,我们着重探讨急性髓系白血病化疗期间准确诊断胃肠道并发症的重要性。消化系统的白血病浸润可能导致黏膜溃疡,进而引发出血或穿孔。该组患者的免疫系统缺陷可能导致坏死性小肠结肠炎(白血病性盲肠炎)、肛周炎症、脓肿及腹膜炎。我们描述了一名37岁男性,于2004年6月就诊,有2个月发热、乏力及咽痛病史,接受过抗生素治疗。体格检查显示面色苍白。入院时外周血细胞计数如下:血红蛋白87g/l,白细胞63×10⁹/l,血小板56×10⁹/l。外周血分类计数显示:原粒细胞4%,多形核中性粒细胞(PMN)20%,单核细胞60%,淋巴细胞16%。骨髓穿刺确诊为急性髓系白血病(AML),根据FAB分类为M5型,骨髓几乎完全被单核样原始细胞浸润。流式细胞术免疫表型评估显示原始细胞与抗CD33、CD13、CD14、CD64、CD15抗体反应,细胞遗传学显示核型正常。诱导治疗方案为:阿糖胞苷2×200mg静脉推注,第1 - 8天;依托泊苷200mg静脉滴注,第1 - 5天;阿柔比星90mg,第1、3、5天。化疗第15天,患者发热38.5℃,伴有腹痛及腹泻(每日10次大便)。立即给予头孢曲松和阿米卡星的广谱抗生素治疗,但病情恶化,腹痛蔓延至全腹,发热及腹泻持续。第18天超声检查显示结肠、部分十二指肠和空肠肠壁增厚。由于怀疑为中性粒细胞减少性小肠结肠炎,抗生素治疗加强,使用替考拉宁、氟康唑、甲硝唑和哌拉西林。患者存在中性粒细胞减少和血小板减少,尽管每天接受来自单一供体的血小板输注。我们开始使用粒细胞集落刺激因子(G - CSF)5μg/kg,持续给药7天。7天后中性粒细胞值达到1×10⁹/l,但发热持续,腹胀及腹泻逐渐改善。发热持续,第30天拔除中心静脉导管。拔除导管后患者病情好转:发热消失。血细胞计数显示血红蛋白91g/l,白细胞3.4×10⁹/l,血小板114×10⁹/l,白细胞分类计数正常。我们强调血液科医生与外科医生在急性白血病化疗期间及化疗后监测胃肠道并发症方面合作的重要性以及腹部超声评估的价值。